10.6084/m9.figshare.11543391.v1 Ayako Fuchigami Ayako Fuchigami Fumika Shigiyama Fumika Shigiyama Toru Kitazawa Toru Kitazawa Yosuke Okada Yosuke Okada Takamasa Ichijo Takamasa Ichijo Mariko Higa Mariko Higa Toru Hiyoshi Toru Hiyoshi Ikuo Inoue Ikuo Inoue Kaoru Iso Kaoru Iso Hidenori Yoshii Hidenori Yoshii Takahisa Hirose Takahisa Hirose Naoki Kumashiro Naoki Kumashiro MOESM5 of Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR) Springer Nature 2020 Type 2 diabetes Cardiometabolic risk factors Dapagliflozin Sitagliptin Glycemic control Weight loss Hypoglycemia 2020-01-08 04:55:41 Journal contribution https://springernature.figshare.com/articles/journal_contribution/MOESM5_of_Efficacy_of_dapagliflozin_versus_sitagliptin_on_cardiometabolic_risk_factors_in_Japanese_patients_with_type_2_diabetes_a_prospective_randomized_study_DIVERSITY-CVR_/11543391 Additional file 5: Table S4. Adverse events.